Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1998 2
2000 1
2001 1
2003 1
2007 1
2010 1
2012 1
2015 1
2017 1
2018 2
2019 2
2021 2
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Eye health indicators for universal health coverage: results of a global expert prioritisation process.
McCormick I, Mactaggart I, Resnikoff S, Muirhead D, Murthy GV, Silva JC, Bastawrous A, Stern J, Blanchet K, Wang N, Yusufu M, Cooper A, Gichangi M; Eye Health Indicators Prioritisation Project Group; Burton MJ, Ramke J. McCormick I, et al. Br J Ophthalmol. 2022 Jul;106(7):893-901. doi: 10.1136/bjophthalmol-2020-318481. Epub 2021 Mar 12. Br J Ophthalmol. 2022. PMID: 33712481 Free PMC article. Review.
Cost-Utility Analysis of Deep Learning and Trained Human Graders for Diabetic Retinopathy Screening in a Nationwide Program.
Srisubat A, Kittrongsiri K, Sangroongruangsri S, Khemvaranan C, Shreibati JB, Ching J, Hernandez J, Tiwari R, Hersch F, Liu Y, Hanutsaha P, Ruamviboonsuk V, Turongkaravee S, Raman R, Ruamviboonsuk P. Srisubat A, et al. Among authors: hanutsaha p. Ophthalmol Ther. 2023 Apr;12(2):1339-1357. doi: 10.1007/s40123-023-00688-y. Epub 2023 Feb 25. Ophthalmol Ther. 2023. PMID: 36841895 Free PMC article.
Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study.
Sangroongruangsri S, Chaikledkaew U, Kumluang S, Wu O, Geue C, Ratanapakorn T, Leelahavarong P, Ingsrisawang L, Ruamviboonsuk P, Taweebanjongsin W, Choovuthayakorn J, Singalavanija A, Hanutsaha P, Kulvichit K, Ratanapojnard T, Wongsawad W, Teerawattananon Y. Sangroongruangsri S, et al. Among authors: hanutsaha p. Clin Drug Investig. 2018 Sep;38(9):853-865. doi: 10.1007/s40261-018-0678-5. Clin Drug Investig. 2018. PMID: 30069864 Free PMC article. Clinical Trial.
A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand.
Kumluang S, Ingsrisawang L, Sangroongruangsri S, Chaikledkaew U, Ratanapakorn T, Ruamviboonsuk P, Taweebanjongsin W, Choovuthayakorn J, Thoongsuwan S, Hanutsaha P, Kulvichit K, Ratanapojnard T, Wongsawad W, Leelahavarong P, Teerawattananon Y. Kumluang S, et al. Among authors: hanutsaha p. BMC Ophthalmol. 2019 Mar 29;19(1):82. doi: 10.1186/s12886-019-1086-1. BMC Ophthalmol. 2019. PMID: 30922350 Free PMC article.
20 results